The Center
Multiple Sclerosis Center Dresden
Patient Information
Contact MSC
Physicians & Nurses
Study Team
Neuropsychology
Mobility Center
The Mobility Center
Walking Assessment
Jump Assessment
DIERS
EMIQ
Projects
Neuroimmunological Laboratory
The NIL
Neurofilament light chain
Autonomic & Neuroendocrinological Functional Laboratory
The ANF
ANF Assessment
MS Living Lab
Management & Science
Team Management & Science
Projects
eHealth & Analytics
MSDS 3D
MSDS Clinic & Practice
MS-HRS
MTRS
Multiple Sclerosis Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Immune cell calender 25
Sherlock-MS-Blog
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
English
Deutsch
English
Unsere Publikationen
A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe
Link
https://doi.org/10.1016/j.msard.2014.09.215
Tags
Multiple Sklerose
MS Behandlung
Jahr
2015
Autoren
Giovannoni G, de Jong B, Derfuss T, Izquierdo G, Mazibrada G, Molyneux P, Nicholas R, Overell J, Ziemssen T, Juliusson G.
Verlag
Mult Scler Relat Disord. 2015 Jan;4(1):83-4.
Zum Eintrag
Graves' disease after treatment with alemtuzumab for multiple sclerosis
Link
https://doi.org/10.14310/horm.2002.1501
Tags
Multiple Sklerose
MS Behandlung
Jahr
2015
Autoren
Tsourdi E, Gruber M, Rauner M, Blankenburg J, Ziemssen T, Hofbauer LC.
Verlag
Horm 2015;14(1):148-153.
Zum Eintrag
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
Link
https://doi.org/10.1186/s12883-015-0342-0
Tags
Multiple Sklerose
MS Behandlung
Jahr
2015
Autoren
Ziemssen T, Kern R, Cornelissen C.
Verlag
BMC Neurol 2015;15(1).
Zum Eintrag
Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination
Link
https://doi.org/10.1038/mp.2014.146
Tags
Multiple Sklerose
MS Behandlung
Jahr
2015
Autoren
Choi EY, Lim JH, Neuwirth A, Economopoulou M, Chatzigeorgiou A, Chung KJ, Bittner S, Lee SH, Langer H, Samus M, Kim H, Cho GS, Ziemssen T, Bdeir K, Chavakis E, Koh JY, Boon L, Hosur K, Bornstein SR, Meuth SG, Hajishengallis G, Chavakis T.
Verlag
Mol Psychiatry. 2015 Jul;20(7):880-888.
Zum Eintrag
Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate
Link
https://doi.org/10.1186/s12883-015-0448-4
Tags
Multiple Sklerose
MS Behandlung
Jahr
2015
Autoren
Ziemssen T, Gilgun-Sherki Y.
Verlag
BMC Neurol 2015;15(1).
Zum Eintrag
Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)
Link
https://doi.org/10.1007/s40120-015-0036-y
Tags
Multiple Sklerose
MS Behandlung
Jahr
2015
Autoren
Ziemssen T, Sylvester L, Rametta M, Ross AP.
Verlag
Neurol Ther 2015;4(2):125-136.
Zum Eintrag
One Year Alemtuzumab - What have we Learned in Clinical Practice? Exchange of Experience between Experts on Treatment of Multiple Sclerosis
Tags
Multiple Sklerose
MS Behandlung
Jahr
2015
Autoren
Bayas A, Baum K, Bitsch A, Haas J, Hellwig K, Lang M, et al.
Verlag
Aktuel Neurol 2015;42(9):535-541.
Zum Eintrag
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease
Link
https://doi.org/10.1186/1471-2377-14-126
Tags
Multiple Sklerose
MS Behandlung
Jahr
2014
Autoren
Thomas K, Schrötter H, Halank M, Ziemssen T.
Verlag
BMC Neurol 2014;14(1).
Zum Eintrag
14
15
16
17
18
Publikationen durchsuchen
Publikationen filtern
Filters
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Show All
Hide
Jahr
-